AI in esophageal cancer: advances, barriers to clinical translation, and perspectives for digital health
Esophageal cancer (EC) remains a major cause of cancer-related morbidity and mortality worldwide.
Background: Esophageal cancer (EC) remains one of the leading causes of cancer-related mortality worldwide. Accurate staging, treatment planning, and prognostic assessment are essential for improving clinical management and patient outcomes. In recent years, artificial intelligence (AI) approaches integrating clinicopathological, imaging, and genomic data have shown considerable potential in these areas. Over the past two years, research in this field has advanced rapidly, supported by the growing availability of large datasets and increasing adoption of multicenter external validation. Recent studies suggest that AI can improve real‑time diagnosis and enhance the prediction of treatment response in patients with EC. This review summarizes recent advances in AI applications for esophageal cancer, discusses current challenges, and highlights future directions for research and clinical implementation.
The high mortality and late diagnosis of esophageal cancer make advances in AI-driven detection, diagnosis, and treatment planning critical for improving patient outcomes.
Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Related signals
- Advances in targeted therapy for esophageal cancer
- A review of esophageal cancer research: emerging trends, progress and perspectives
- An esophageal cancer clinical trial - ES3
- Case Report: Small bowel metastasis from esophageal squamous cell carcinoma: a case series and systematic review of clinical characteristics, tropism, and survival outcomes
- Current landscape of immunotherapy in esophageal cancer: a literature review